MYC's effect on glutaminolysis was cohesive in the various cancer types, with an associated increase demonstrated in hepatocellular carcinoma, pancreatic ductal adenocarcinoma, and renal cell carcinoma. This evidence concerns the gene MYC and hereditary clear cell renal cell carcinoma.